Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression
Clinical trial NCT03125200 · TERMINATED
Trial details
- NCT number
- NCT03125200
- Sponsor
- ADC Therapeutics S.A.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-18
- Primary completion
- 2018-04-05
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.